Detalhe da pesquisa
1.
Tofacitinib in Pregnancy: Assessing Pregnancy and Infant Outcomes, Cord Blood, and Breast Milk Concentrations.
Clin Gastroenterol Hepatol
; 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38309493
2.
Validation and Update of the Lémann Index to Measure Cumulative Structural Bowel Damage in Crohn's Disease.
Gastroenterology
; 161(3): 853-864.e13, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34052277
3.
Natural disease course of Crohn's disease during the first 5 years after diagnosis in a European population-based inception cohort: an Epi-IBD study.
Gut
; 68(3): 423-433, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29363534
4.
Disease course of inflammatory bowel disease unclassified in a European population-based inception cohort: An Epi-IBD study.
J Gastroenterol Hepatol
; 34(6): 996-1003, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-30562421
5.
What Can We Learn from Epidemiological Studies in Inflammatory Bowel Disease?
Dig Dis
; 35(1-2): 69-73, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28147360
6.
Discontinuation of anti-tumor necrosis factor therapy in inflammatory bowel disease patients: a prospective observation.
Scand J Gastroenterol
; 51(2): 196-202, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26329773
7.
Serum trough infliximab levels: A comparison of three different immunoassays for the monitoring of CT-P13 (infliximab) treatment in patients with inflammatory bowel disease.
Biologicals
; 44(1): 33-6, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26603635
8.
Pregnancy and newborn outcome of mothers with inflammatory bowel diseases exposed to anti-TNF-α therapy during pregnancy: three-center study.
Scand J Gastroenterol
; 48(8): 951-8, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23834232
9.
Subcutaneous Infliximab in Refractory Crohn's Disease Patients: A Possible Biobetter?
Crohns Colitis 360
; 5(4): otad040, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-38028954
10.
The cost of inflammatory bowel disease in high-income settings: a Lancet Gastroenterology & Hepatology Commission.
Lancet Gastroenterol Hepatol
; 8(5): 458-492, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36871566
11.
Cellular and Humoral Immune Responses to SARS-CoV-2 Vaccination in Inflammatory Bowel Disease Patients.
J Crohns Colitis
; 16(9): 1347-1353, 2022 Sep 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35358307
12.
Anti-SARS-CoV-2 Vaccination and Antibody Response in Patients With Inflammatory Bowel Disease on Immune-modifying Therapy: Prospective Single-Tertiary Study.
Inflamm Bowel Dis
; 28(10): 1506-1512, 2022 10 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34849919
13.
Safety of Ustekinumab and Vedolizumab During Pregnancy-Pregnancy, Neonatal, and Infant Outcome: A Prospective Multicentre Study.
J Crohns Colitis
; 16(12): 1808-1815, 2022 Dec 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35708729
14.
Implementation and Short-term Adverse Events of Anti-SARS-CoV-2 Vaccines in Inflammatory Bowel Disease Patients: An International Web-based Survey.
J Crohns Colitis
; 16(7): 1070-1078, 2022 Aug 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35037033
15.
Fecal Microbial Transplantation versus Mesalamine Enema for Treatment of Active Left-Sided Ulcerative Colitis-Results of a Randomized Controlled Trial.
J Clin Med
; 10(13)2021 Jun 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-34206663
16.
Differences in the placental pharmacokinetics of vedolizumab and ustekinumab during pregnancy in women with inflammatory bowel disease: a prospective multicentre study.
Therap Adv Gastroenterol
; 14: 17562848211032790, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34394725
17.
Risk of extra-intestinal cancer in inflammatory bowel disease: meta-analysis of population-based cohort studies.
Am J Gastroenterol
; 105(7): 1480-7, 2010 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-20332773
18.
Anti-inflammatory effect of biological treatment in patients with inflammatory bowel diseases: calprotectin and IL-6 changes do not correspond to sRAGE changes.
Scand J Clin Lab Invest
; 70(4): 294-9, 2010 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-20446880
19.
The use of 5-aminosalicylate for patients with Crohn's disease in a prospective European inception cohort with 5 years follow-up - an Epi-IBD study.
United European Gastroenterol J
; 8(8): 949-960, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32715989
20.
Health-care costs of inflammatory bowel disease in a pan-European, community-based, inception cohort during 5 years of follow-up: a population-based study.
Lancet Gastroenterol Hepatol
; 5(5): 454-464, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32061322